BIOTRONIK

Company Snapshot

Founded: 1963
Entity Type: Private
Region: Europe
Headquarter: Berlin, Germany
Key Geographics: North America, Europe, South and Central America, Asia-Pacific
Corporate Address: Woermannkehre 1 12359 Berlin Germany Tel: +49-30-68905-0 Web: www.biotronik.com

Company Overview

Biotronik (Biotronik SE & Co. KG) is a privately held global medical technology company that specializes in cardiovascular, endovascular, and neuromodulation solutions. Its portfolio covers several main categories, including cardiac rhythm management (pacemakers, implantable defibrillators, cardiac resynchronization devices, and remote patient monitoring systems), electrophysiology (diagnostic and ablation catheters), vascular intervention (stents, scaffolds, balloon catheters for coronary and peripheral artery disease), and neuromodulation (spinal cord stimulation systems for chronic pain relief).

BIOTRONIK In Reports

Cardiovascular Devices: Global Markets to 2030

BCC Research detailed report on cardiovascular devices market data using 2024 as the base year 2025 as the estimated year, and provides CAGR projections for the 2025–2030 forecast period.

Pacemakers: Global Markets

BCC Research detailed report on pacemaker market revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period from 2025 through 2030.

Technologies for Long-Term Care and Home Healthcare: Global Markets

According to BCC Research detailed report on technologies for long-term care and home healthcare market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates through 2030.

Company's Business Segments

  • Cardiac Rhythm Management (CRM) : CRM portfolio includes pacemakers, implantable defibrillators, and external remote monitoring systems for cardiac arrhythmias patients.
  • Electrophysiology : It offers an arrhythmia for an individual patient treatment.
  • Vascular Intervention : It provides stents, scaffolds, balloon catheters, and drug-coated products to effectively treat coronary and peripheral artery disease. 
  • Neuromodulation : It improves patient care with chronic intractable pain and minimizes the burden on caregivers, clinicians, and patients.

Applications/End User Industries

  • Healthcare
  • Cardiology
  • Life Sciences
  • Cardiac Rhythm Management (CRM)
  • Vascular
  • Hospitals and Clinics
AI Sentiment